This person is not registered. Is this you?


Profile Details
Luk Chui Li
Affiliations:

Abbott Laboratories

 
100 Abbott Park Rd
Building AP4, Dept R43D
Abbott Park, IL 60064-6075 US
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@SyrianCoalition
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Antibodies, Biotechnology, Drug Design, Monoclonal, Peptides
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 5928 / 3065 (What's this?)
Accomplish Score: 31
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 82
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (13 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 3 (18 / 0)
  • Rationale: Docetaxel-mediated chemotherapy is the first-line standard approach and has been determined to show a survival advantage for metastatic castration-resistant prostate cancer (mCRPC) patients. ()
  • Co-occurrence of Flt3ITD and TET2 mutations provoke an animal model of AML by epigenetic repression of Wnt pathway antagonists, including RUNX3, and by hyperexpression of ID1, encoding Wnt agonist. ()
  • BACKGROUND: As the value of radiotherapy (RT) in intensive care unit (ICU) patients with lung cancer is of uncertain efficacy, we evaluated characteristics, outcomes and RT utilization for such patients in Ontario, Canada. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.